SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exelixis, Inc. – ‘S-8’ on 8/9/22

On:  Tuesday, 8/9/22, at 4:35pm ET   ·   Effective:  8/9/22   ·   Accession #:  939767-22-99   ·   File #:  333-266707

Previous ‘S-8’:  ‘S-8’ on 8/6/20   ·   Latest ‘S-8’:  This Filing   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/09/22  Exelixis, Inc.                    S-8         8/09/22    4:274K

Registration Statement – Securities for an Employee Benefit Plan   —   Form S-8   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     80K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     11K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      6K 
 4: EX-FILING FEES  Filing Fees                                     HTML     14K 


‘S-8’   —   Registration Statement – Securities for an Employee Benefit Plan

Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Power of Attorney (contained on signature page)

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

As filed with the Securities and Exchange Commission on August 9, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
exellogo201709a04a.jpg
EXELIXIS, INC.
(Exact name of registrant as specified in its charter)
Delaware04-3257395
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
1851 Harbor Bay Parkway
Alameda, CA 94502
(Address of Principal Executive Offices, including Zip Code)
AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN
(Full Title of the Plans)
Michael M. Morrissey
President and Chief Executive Officer
Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda, CA 94502
(650) 837-7000
(Name, Address, and Telephone Number, including Area Code, of Agent for Service)
Copies to:
Jeffrey J. HessekielChadwick L. Mills
Executive Vice President, General Counsel and SecretaryCooley LLP
Exelixis, Inc.
101 California Street, 5th Floor
1851 Harbor Bay Parkway
San Francisco, CA 94111
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerýAccelerated filer
¨
Non-accelerated filer
¨ (Do not check if a smaller reporting company)
Smaller reporting company
¨
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨



EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 28,500,000 shares of the Common Stock to be issued pursuant to the Amended and Restated 2017 Equity Incentive Plan (the "2017 Plan"). The shares of the Common Stock previously reserved for issuance under the 2017 Plan were registered on the Registrant’s Registration Statements on Form S-8 previously originally filed with the Securities and Exchange Commission on May 25, 2017 (File No. 333-218236), August 1, 2018 (File No. 333-226493) and August 6, 2020 (File No. 333-241667) (as amended, collectively, the “Prior Registration Statements”).
This Registration Statement on Form S-8 relates to securities of the same class as that to which the Prior Registration Statements relate, and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statements, to the extent relating to the registration of Common Stock issuable under the 2017 Plan, are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents filed by Exelixis, Inc. (the “Company”) with the Securities and Exchange Commission (the “Commission”) are incorporated by reference into this registration statement:
The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”), filed on February 18, 2022;
The information specifically incorporated by reference Part III of the Form 10-K from the Company’s proxy statement on Schedule 14A filed April 14, 2022;
The Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2022, filed on May 10, 2022;
The Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2022, filed on August 9, 2022;
The Company’s Current Reports on Form 8-K filed on February 23, 2022, April 13, 2022, May 27, 2022, July 19, 2022; and
The description of the Company’s common stock that is contained in the Company’s Registration Statement on Form 8-A (File No. 000-30235), filed with the Commission on April 6, 2000, pursuant to Section 12 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description, including Exhibit 4.2 to the Form 10-K.
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this registration statement and prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this registration statement from the date of the filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein, or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.



ITEM 8. EXHIBITS
Exhibit
Number
Exhibit Description
Incorporation by Reference
Filed
Herewith
Form
File Number
Exhibit/
Appendix
Reference
Filing Date
4.110-Q000-302353.18/5/2021
4.28-K000-302353.13/3/2021
5.1X
23.1X
23.2X
24.1X
99.110-Q000-3023510.18/9/2022
107 X

3


SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S‑8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Alameda, State of California, on August 9, 2022.
EXELIXIS, INC.
By: /s/ Michael M. Morrissey
Michael M. Morrissey, Ph. D.
President and Chief Executive Officer

POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael M. Morrissey, Christopher J. Senner and Jeffrey J. Hessekiel, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

Signature  Title Date
/s/ Michael M. Morrissey  Director, President and August 9, 2022
Michael M. Morrissey, Ph.D.Chief Executive Officer (Principal Executive Officer)
/s/ Christopher J. Senner  Executive Vice President and  August 9, 2022
Christopher J. Senner
Chief Financial Officer
(Principal Financial and Accounting Officer)
/s/ Stelios Papadopoulos  Chairman of the Board August 9, 2022
Stelios Papadopoulos, Ph.D.
/s/ Carl B. Feldbaum  Director August 9, 2022
Carl B. Feldbaum, Esq.
/s/ Maria C. Freire  Director August 9, 2022
Maria C. Freire, Ph.D.
/s/ Alan M. Garber  Director August 9, 2022
Alan M. Garber, M.D., Ph.D.
4


Signature  Title Date
/s/ Vincent T. Marchesi  Director August 9, 2022
Vincent T. Marchesi, M.D., Ph.D.
/s/ George Poste  Director August 9, 2022
George Poste, D.V.M., Ph.D., FRS
/s/ Julie A. Smith  Director August 9, 2022
Julie A. Smith
 
/s/ Lance Willsey  Director August 9, 2022
Lance Willsey, M.D.
/s/ Jacqueline Wright  Director August 9, 2022
Jacqueline Wright
/s/ Jack L. Wyszomierski  Director August 9, 2022
Jack L. Wyszomierski

5

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8’ Filing    Date    Other Filings
Filed on / Effective on:8/9/2210-Q,  8-K
7/1/2210-Q
5/10/2210-Q,  8-K
4/14/22DEF 14A,  DEFA14A
4/1/2210-Q
2/18/2210-K
12/31/2110-K,  5
8/6/2010-Q,  8-K,  S-8
8/1/1810-Q,  4,  8-K,  S-8,  S-8 POS
5/25/174,  4/A,  8-K,  S-8
4/6/008-A12G
 List all Filings 


11 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/22  Exelixis, Inc.                    10-Q        7/01/22   73:11M
 7/19/22  Exelixis, Inc.                    8-K:8       7/18/22   10:413K
 5/27/22  Exelixis, Inc.                    8-K:5       5/25/22   10:451K
 5/10/22  Exelixis, Inc.                    10-Q        4/01/22   72:7.7M
 4/14/22  Exelixis, Inc.                    DEF 14A     5/25/22    1:3.7M                                   Donnelley … Solutions/FA
 4/13/22  Exelixis, Inc.                    8-K:5       4/11/22   10:409K
 2/23/22  Exelixis, Inc.                    8-K:8       2/23/22   10:411K
 2/18/22  Exelixis, Inc.                    10-K       12/31/21   93:11M
 8/05/21  Exelixis, Inc.                    10-Q        7/02/21   71:7.7M
 3/03/21  Exelixis, Inc.                    8-K:3,5,9   2/25/21   13:651K
 4/06/00  Exelixis, Inc.                    8-A12G                 1:5K                                     Donnelley Fin’l S… 13/FA
Top
Filing Submission 0000939767-22-000099   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 8:23:33.1pm ET